Literature DB >> 22172304

Targeting of intermittent preventive treatment for malaria.

Richard W Steketee1, Laurence Slutsker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22172304     DOI： 10.1016/S1473-3099(11)70335-8

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  2 in total

1.  Delivery strategies for malaria chemoprevention with monthly dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years old in Malawi: a protocol for a cluster randomized trial.

Authors:  Thandile Gondwe; Bjarne Robberstad; Mavuto Mukaka; Siri Lange; Bjørn Blomberg; Kamija Phiri
Journal:  BMC Pediatr       Date:  2018-07-20       Impact factor: 2.125

2.  Malaria chemoprevention with monthly dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years in Uganda and Kenya: study protocol for a multi-centre, two-arm, randomised, placebo-controlled, superiority trial.

Authors:  Titus K Kwambai; Aggrey Dhabangi; Richard Idro; Robert Opoka; Simon Kariuki; Aaron M Samuels; Meghna Desai; Michael Boele van Hensbroek; Chandy C John; Bjarne Robberstad; Duolao Wang; Kamija Phiri; Feiko O Ter Kuile
Journal:  Trials       Date:  2018-11-06       Impact factor: 2.279
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.